Literature DB >> 29746358

Delayed Cerebral Injury in Adults With Bacterial Meningitis: A Novel Complication of Adjunctive Steroids?

Cinthia Gallegos1, Farrell Tobolowsky, Masayuki Nigo, Rodrigo Hasbun.   

Abstract

OBJECTIVES: To report the prevalence of delayed cerebral injury in adults with bacterial meningitis and explore its association with adjunctive steroids.
DESIGN: Retrospective analysis of adults with bacterial meningitis between 2005 and 2016.
SETTING: Ten hospitals in the Greater Houston area. PATIENTS: Consecutive subjects with culture proven community-acquired bacterial meningitis. INTERVENTION: Subjects were categorized as receiving or not adjunctive steroids within 4 hours.
MEASUREMENTS AND MAIN RESULTS: A total of 120 patients were identified who were admitted with community-acquired bacterial meningitis. Delayed cerebral injury was seen in five of 120 patients (4.1%); all five patients had fever and abnormal neurologic examinations. Adjunctive steroids within 4 hours were more likely given to those with delayed cerebral injury (5/5,100% vs 43/115, 37.5%; p = 0.01). Of the patients who developed delayed cerebral injury, three had Streptococcus pneumoniae, one had methicillin-resistant Staphylococcus aureus, and one had Listeria monocytogenes isolated. We observed an adverse clinical outcome as defined by the Glasgow Outcome Scale in four of the five patients (80%).
CONCLUSIONS: Delayed cerebral injury occurred in 4.1% of adults with bacterial meningitis, and it was associated with the use of adjunctive steroids. Future studies should explore the etiology and prevention of this devastating complication.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29746358     DOI: 10.1097/CCM.0000000000003220

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Emergence of Ceftriaxone Resistance during a Case of Pneumococcal Meningitis with Fatal Evolution.

Authors:  A Mizrahi; J C Marvaud; B Pilmis; J C Nguyen Van; C Couzigou; C Bruel; N Engrand; A Le Monnier; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

2.  Case Commentary: Delayed Cerebral Vasculitis Associated with the Development of Ceftriaxone-Resistant Pneumococcal Meningitis.

Authors:  Rodrigo Hasbun
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

3.  Neutrophil-to-lymphocyte ratio is associated with increased cerebral blood flow velocity in acute bacterial meningitis.

Authors:  Lena Hueske; Tobias Bobinger; Antje Giede-Jeppe; Selim Atay; Julia Koehn; Anne Mrochen; Hannes Luecking; Philip Hoelter; Bastian Volbers; Hagen B Huttner
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

4.  Critical care management of infectious meningitis and encephalitis.

Authors:  Geert Meyfroidt; Pedro Kurtz; Romain Sonneville
Journal:  Intensive Care Med       Date:  2020-01-14       Impact factor: 41.787

5.  Adjuvant Cannabinoid Receptor Type 2 Agonist Modulates the Polarization of Microglia Towards a Non-Inflammatory Phenotype in Experimental Pneumococcal Meningitis.

Authors:  Steven D Pan; Denis Grandgirard; Stephen L Leib
Journal:  Front Cell Infect Microbiol       Date:  2020-11-05       Impact factor: 5.293

Review 6.  The Use of Adjunctive Steroids in Central Nervous Infections.

Authors:  Shalini Gundamraj; Rodrigo Hasbun
Journal:  Front Cell Infect Microbiol       Date:  2020-11-23       Impact factor: 5.293

7.  Atypical Streptococcal Meningitis with Fatal Cerebrovascular Complications: A Case Report.

Authors:  Gabriel D Pinilla-Monsalve; Daniel F Torres-Cutiva; Juan P Fernández-Cubillos
Journal:  Infect Dis Rep       Date:  2020-11-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.